analyzeportfolio
NYSE · Materials

Ingevity Corp (NGVT)

As-reported financials and SEC filings for Ingevity Corp. The latest annual period is FY2025. The latest reported quarter is Q2 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About Ingevity Corp

Ingevity Corporation develops and manufactures specialty materials and chemicals used in applications such as automotive gasoline vapor emissions control, filtration for food and water, asphalt paving, agrochemical dispersants, bioplastics, coatings, and road markings. The company operates primarily through two business segments: Performance Materials and Pavement Technologies, serving industries including automotive, construction, agriculture, and packaging. Ingevity focuses on products that are largely renewably sourced and aims to provide sustainable solutions for its customers worldwide.

Snapshot

Revenue
$1.17B
Revenue growth (YoY)
-2.7%
Net income
$-167.1M
Diluted EPS
$-4.61
Gross margin
39.5%
Operating margin
35.9%
Net margin
-14.3%
FCF margin
23.4%
ROE
-562.6%
net income / fiscal-year-end equity
P/E
trailing when available, otherwise FY EPS
Market cap
$2.39B
Long-term debt / equity
39.10×
non-current term debt only

Fundamentals are from SEC filings for FY2025, the latest annual period (ended December 31, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.

What changed at Ingevity

  • Revenue fell 2.7% to $1.2B in FY2025, after a 1.3% decline the year before.
  • Operating margin is 35.9% in FY2025, +5.5 pp against 30.3% in FY2021.
  • Most recent quarter Q2 FY2026: revenue $314M, down 5.2% from Q2 FY2025.
  • Free cash flow was $274M in FY2025, 23.4% of revenue.
  • Net loss narrowed to $167M in FY2025, from $430M in FY2024.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Ingevity’s fundamentals sit among the 241 Materials companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Gross margin39.5%
76th percentile of 191
Operating margin35.9%
97th percentile of 189
Net margin-14.3%
15th percentile of 221
FCF margin23.4%
96th percentile of 205
Revenue growth (YoY)-2.7%
31st percentile of 236
ROE-562.6%
2nd percentile of 216
Long-term debt / equity39.10×
Highest of 165
Short interest5.04d
70th percentile of 238

Ingevity’s long-term debt to equity of 39.10 is the highest of the 165 Materials companies reporting it. Ingevity’s return on equity of -562.6% ranks in the 2nd percentile of the 216 Materials companies reporting it. Ingevity’s operating margin of 35.9% ranks in the 97th percentile of the 189 Materials companies reporting it.

No reported insider purchases (code P) in the last 90 days; 7 insider sales totaling $1.7M. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →

Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 2 of the superinvestors we track (plus 6 quant / multi-strat books), based on each investor’s most recent 13F; periods vary by investor (newest: Q2 2026).

Conviction investors
2
+6 quant / multi-strat
Initiated / added
5
1 new, 4 added
Reduced / exited
3
3 trimmed, 0 exited
Combined position
$87.1M
reported long value
InvestorAs ofPosition valueSharesChange
Millennium ManagementquantQ2 2026$74.1M992.0KReduced
Renaissance TechnologiesquantQ2 2026$4.7M63.2KReduced
AQR Capital ManagementquantQ2 2026$2.6M34.9KAdded
Bridgewater AssociatesQ2 2026$1.6M20.8KAdded
Gotham Asset ManagementQ2 2026$1.3M17.8KAdded
Citadel AdvisorsquantQ2 2026$1.2M16.7KAdded
Point72 Asset ManagementquantQ2 2026$1.1M14.8KReduced
Two Sigma InvestmentsquantQ2 2026$440,5535.9KNew

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.

Buys (90d)
0
code P
Bought (90d)
code P value
Sells (90d)
7
$1.7M
Reported activity
Net selling
by $ value, 90d
Trade dateInsiderTypeSharesPriceValue
2026-08-18
Li David HPresident & CEOSell92$74.71$7K
2026-08-17
filed 2026-08-18
Li David HPresident & CEOSell5.0K$75.83$379K
2026-08-14
filed 2026-08-18
Li David HPresident & CEOSell5.0K$75.73$379K
2026-08-13
filed 2026-08-14
Li David HPresident & CEOSell5.0K$75.73$379K
2026-08-12
filed 2026-08-14
Li David HPresident & CEOSell5.0K$76.62$383K
2026-08-03
filed 2026-08-04
Fisher Ryan C.SVP, Gen. Counsel & SecretarySell1.4K$73.76$103K
2026-08-03
filed 2026-08-04
Fisher Ryan C.SVP, Gen. Counsel & SecretarySell1.3K$73.67$97K
2026-05-28
filed 2026-06-01
DYER TERRANCE MSVP, Chief HR OfficerSell266$68.45$18K
2026-05-28
filed 2026-06-01
DYER TERRANCE MSVP, Chief HR OfficerSell200$68.53$14K
2026-05-28
filed 2026-06-01
DYER TERRANCE MSVP, Chief HR OfficerSell30$68.57$2K

Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
1.3M
settled 2026-08-14
Change vs prior
+1.4%
vs previous settlement
Days to cover
5.04
at avg daily volume
Avg daily volume
248.1K
FINRA reported
SettlementShares shortChangeDays to cover
2026-08-141.3M+1.4%5.04
2026-07-311.2M+3.0%4.96
2026-07-151.2M+4.8%5.43
2026-06-301.1M+4.9%2.75
2026-06-151.1M+15.8%4.65
2026-05-29942.0K-8.6%4.28
2026-05-151.0M-7.7%3.74
2026-04-301.1M-3.0%5.26

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2023FY2022FY2021
Revenue$1.17B$1.20B$1.22B$1.67B$1.39B
Gross profit$461.5M$464.8M$445.0M$570.1M$512.8M
Operating income$418.7M$425.9M$423.2M$452.6M$422.2M
Net income$-167.1M$-430.3M$-5.4M$211.6M$118.1M
Diluted EPS$-4.61$-11.85$-0.15$5.50$2.95

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Balance sheet (as reported)

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Cash flow (as reported)

 FY2025FY2024FY2023FY2022FY2021
Operating cash flow$331.2M$128.6M$205.1M$313.4M$293.3M
Capital expenditure$57.7M$77.6M$109.8M$142.5M$103.8M
Free cash flow$273.5M$51.0M$95.3M$170.9M$189.5M

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Quarterly trend (as reported)

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q2 FY2026$314.1M-5.2%$35.3M$1.00
Q1 FY2026$258.0M4.1%$59.8M$1.66
Q4 FY2025$255.1M-3.1%$-84.6M$-2.37
Q3 FY2025$333.1M-0.2%$43.5M$1.18
Q2 FY2025$331.5M-15.1%$-146.5M$-4.02
Q1 FY2025$247.9M-27.1%$20.5M$0.56
Q4 FY2024$263.3M$16.6M$0.46
Q3 FY2024$333.8M-25.2%$-107.2M$-2.94

Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.

Company facts

ExchangeNYSE
SectorMaterials
SIC industryChemicals & Allied Products
Latest annual periodFY2025 (ended December 31, 2025)
Latest reported quarterQ2 FY2026 (ended June 30, 2026)
Oldest indexed filing2015
SEC CIK1653477

Selected SEC filings

10-Q2026-07-30
View on EDGAR →
10-Q2026-05-07
View on EDGAR →
8-K2026-07-29
View on EDGAR →
8-K2026-06-24
View on EDGAR →
8-K2026-05-06
View on EDGAR →
8-K2026-05-04
View on EDGAR →

Largest Materials peers

All Materials companies →

Monitor NGVT

Get an alert when Ingevity files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor NGVT free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.